URL copied Remdesivir is not a life saving drug , says Centre.
Amid the rising cases of coronavirus pandemic across the nation, the Ministry of Health and Family Welfare informed the citizens regarding usage of key anti-viral drug Remdesivir Remdesivir is not a life-saving drug in COVID-19. It is to be administered only in the hospital settings, the ministry said in a tweet.
The ministry also mentioned several other features and relevant information related to the injectable drug.
1. Remdesivir is an experimental investigational drug granted emergency authorisation use.Â
2. It is not a life saving drug in COVID-19 pandemic.Â
3. Studies do not demonstrate mortality reduction with this drug.Â
Take strict action against those indulged in black marketing, hoarding of remdesivir: Centre to states
SECTIONS
Last Updated: Apr 19, 2021, 06:37 PM IST
Share
Synopsis
Black marketing, hoarding of remdesivir is being strictly monitored and state governments have been advised to take strict action against those indulging in such malpractices, Chemicals and Fertilisers Minister D V Sadananda Gowda said.
On Saturday, the National Pharmaceutical Pricing Authority (NPPA) had announced that the pharmaceutical companies like Cadila Healthcare, Dr Reddy s Laboratories and Cipla have reduced the price of their respective brands of remdesivir injection (100mg/vial).
State governments have been asked to take strict action against anyone found indulged in black marketing or hoarding of antiviral drug remdesivir, Chemicals and Fertilisers Minister D V Sadananda Gowda said on Monday. The minister said he has also taken a meeting with the pharma secretary to review the availability of the a
The government plans to double the production of antiviral drug remdesivir to around 3 lakh vials per day over the next 15 days, to make it available readily for the treatment of COVID-19. Minister of State of Chemicals and Fertilisers Mansukh L Mandaviya tweeted that the process has already started to enhance the production of remdesivir in the country. We are trying to increase production of remdesivir injection and also that its price comes down. Currently, we are producing 1.5 lakh vials per day. In the next fifteen days, it will be doubled to 3 lakh vials per day, he said on Twitter. The government has also given permission to 20 plants to produce the antiviral drug, he added.
Remdesivir Prices Cut On Government Intervention: Industry Body Remdesivir Prices Cut On Government Intervention: Industry Body Drug companies like Cadila Healthcare, Dr Reddy s Laboratories and Cipla have cut the prices of their respective brands of remdesivir injection (100 mg/vial). The antiviral drug is used in the treatment of COVID-19.
Drug companies have reduced the price of Remdesivir injections.
New Delhi:
To enhance the availability of remdesivir injection, used in the treatment of COVID-19, pharmaceutical companies have reduced the price following the government s intervention, the National Pharmaceutical Pricing Authority (NPPA) said on Saturday.
Drug companies like Cadila Healthcare, Dr Reddy s Laboratories and Cipla have cut the prices of their respective brands of remdesivir injection (100 mg/vial). The antiviral drug is used in the treatment of COVID-19.
Pharma companies cut remdesivir injection prices on govt intervention: NPPA
SECTIONS
Last Updated: Apr 17, 2021, 07:22 PM IST
Share
Synopsis
According to the details shared by the NPPA, Cadila Healthcare has reduced the price of its REMDAC (Remdesivir 100 mg) injection to Rs 899 from Rs 2,800 earlier. Similarly, Syngene International has cut the price of its brand RemWin to Rs 2,450 from Rs 3,950 earlier.
Agencies
According to the details shared by the NPPA, Cadila Healthcare has reduced the price of its REMDAC (Remdesivir 100 mg) injection to Rs 899 from Rs 2,800 earlier.
Prices of remdesivir injection have been voluntarily curtailed by various drug companies on the intervention of the government, National Pharmaceutical Pricing Authority (NPPA) said on Saturday.